Summit Therapeutics plc

Summit Therapeutics plc is not a good value stock. Summit Therapeutics plc is not a good growth stock. Summit Therapeutics plc is a mediocre stock to choose.

Summit Therapeutics Plc is a holding company, which engages in the discovery, development, and comme...

News

Why Summit Therapeutics Stock Is Soaring Again Today

Fool.com Headlines Shares of Summit Therapeutics (NASDAQ: SMMT) were soaring 22.5% higher as of 11:18 a.m. ET on Thursday. The gain came after the clinical-stage biopharmaceutical company revealed that it entered into...\n more…

Summit Therapeutics, With 85% Gain This Week, Rockets Again On $235 Million Sale

Yahoo! Finance: News Summit Therapeutics stock rocketed again Thursday - adding onto an 85% gain this week - after raising $235 million in a private placement.\n more…

Summit Therapeutics Surges on Trial Results: Time to Buy?

MarketBeat - AP News Summit Therapeutics has surged almost 100% this week, driven by positive Phase III trial results for its cancer therapy Ivonescimab...\n more…

Why Summit Therapeutics (SMMT) Stock Is Rising Today

Benzinga Summit Therapeutics shares are trading higher by 5.1% Thursday morning. The company announced it raised $235 million in net proceeds.\n more…

Summit Therapeutics jumps 4%, raises $235M

SeekingAlpha.com: All News Summit Therapeutics raises $235 million from biotech investors, with insiders contributing $79 million.\n more…

Summit Therapeutics raises $235M

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…